BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34257703)

  • 21. Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood.
    Wang BH; Li YY; Han JZ; Zhou LY; Lv YQ; Zhang HL; Zhao L
    Oncotarget; 2017 May; 8(19):31692-31704. PubMed ID: 28404957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
    Diaz-Lagares A; Mendez-Gonzalez J; Hervas D; Saigi M; Pajares MJ; Garcia D; Crujerias AB; Pio R; Montuenga LM; Zulueta J; Nadal E; Rosell A; Esteller M; Sandoval J
    Clin Cancer Res; 2016 Jul; 22(13):3361-71. PubMed ID: 26842235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
    Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
    Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of support vector machines for computer aided diagnosis of lung cancer in CT based on a multi-dimensional data set.
    Sun T; Wang J; Li X; Lv P; Liu F; Luo Y; Gao Q; Zhu H; Guo X
    Comput Methods Programs Biomed; 2013 Aug; 111(2):519-24. PubMed ID: 23727300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.
    Begum S; Brait M; Dasgupta S; Ostrow KL; Zahurak M; Carvalho AL; Califano JA; Goodman SN; Westra WH; Hoque MO; Sidransky D
    Clin Cancer Res; 2011 Jul; 17(13):4494-503. PubMed ID: 21610147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules.
    Liu QX; Zhou D; Han TC; Lu X; Hou B; Li MY; Yang GX; Li QY; Pei ZH; Hong YY; Zhang YX; Chen WZ; Zheng H; He J; Dai JG
    Adv Sci (Weinh); 2021 Jul; 8(13):2100104. PubMed ID: 34258160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
    Wang X; Wang X; Li X; Chang Y
    J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
    Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
    Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a serological molecular model for the early diagnosis and progression monitoring of bone metastasis in lung cancer.
    Teng X; Wei L; Han L; Min D; Du Y
    BMC Cancer; 2020 Jun; 20(1):562. PubMed ID: 32546271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
    Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
    BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
    Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
    Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic markers of urothelial cancer based on DNA methylation analysis.
    Chihara Y; Kanai Y; Fujimoto H; Sugano K; Kawashima K; Liang G; Jones PA; Fujimoto K; Kuniyasu H; Hirao Y
    BMC Cancer; 2013 Jun; 13():275. PubMed ID: 23735005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of a panel of plasma microRNA biomarkers for lung cancer.
    Li J; Fang H; Jiang F; Ning Y
    Biomark Med; 2019 Dec; 13(18):1557-1564. PubMed ID: 31674214
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
    Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
    Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules.
    Zhou J; Cheng T; Li X; Hu J; Li E; Ding M; Shen R; Pineda JP; Li C; Lu S; Yu H; Sun J; Huang W; Wang X; Si H; Shi P; Liu J; Chang M; Dou M; Shi M; Chen X; Yung RC; Wang Q; Zhou N; Bai C
    Clin Epigenetics; 2021 Dec; 13(1):220. PubMed ID: 34906185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.